About AbCellera
Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Vancouver, British Columbia
- Founded
- 2012
- Company type
- Public Company
AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
Specialties
- Antibody Discovery
- Cell Culture
- Antibody Therapies
- Protein Analysis
- Microfluidic Single Cell Analysis
- Single Cell Genomics
- Monoclonal Antibody Discovery
- Cell Enrichment
- Cell Screening
- Cell Recovery
- Protein engineering
- T cell engagers
- and Bispecifics
Company locations
150 W 4th Ave, Vancouver, British Columbia V5Y 1G6, CA
41-45 Bourke Rd, Alexandria, New South Wales 2015, AU
7236 Rue Waverly, Montreal, Quebec H2R 0C2, CA
810 Evans Ave, Vancouver, British Columbia V6A 2L2, CA
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 42,472
- People linked to this company
- 582
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.